- Home
- PULM vs MTEX Comparison
PULM vs MTEX Comparison
Compare PULM & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- MTEX
- Stock Information
- Founded
- PULM 2003
- MTEX 1993
- Country
- PULM United States
- MTEX United States
- Employees
- PULM N/A
- MTEX N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- PULM Health Care
- MTEX Health Care
- Exchange
- PULM Nasdaq
- MTEX Nasdaq
- Market Cap
- PULM 33.2M
- MTEX 20.0M
- IPO Year
- PULM N/A
- MTEX 1999
- Fundamental
- Price
- PULM $6.38
- MTEX $8.67
- Analyst Decision
- PULM
- MTEX
- Analyst Count
- PULM 0
- MTEX 0
- Target Price
- PULM N/A
- MTEX N/A
- AVG Volume (30 Days)
- PULM 60.0K
- MTEX 19.2K
- Earning Date
- PULM 08-12-2025
- MTEX 08-12-2025
- Dividend Yield
- PULM N/A
- MTEX N/A
- EPS Growth
- PULM N/A
- MTEX N/A
- EPS
- PULM N/A
- MTEX N/A
- Revenue
- PULM $1,921,000.00
- MTEX $115,036,000.00
- Revenue This Year
- PULM N/A
- MTEX N/A
- Revenue Next Year
- PULM $134.88
- MTEX N/A
- P/E Ratio
- PULM N/A
- MTEX N/A
- Revenue Growth
- PULM N/A
- MTEX N/A
- 52 Week Low
- PULM $1.78
- MTEX $7.00
- 52 Week High
- PULM $10.40
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- PULM 39.53
- MTEX 42.52
- Support Level
- PULM $6.26
- MTEX $8.41
- Resistance Level
- PULM $6.96
- MTEX $9.90
- Average True Range (ATR)
- PULM 0.85
- MTEX 0.76
- MACD
- PULM -0.11
- MTEX -0.04
- Stochastic Oscillator
- PULM 39.71
- MTEX 16.30
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.